Opportunities Assessment for Hepatitis B Therapeutics in Thailand

Product Code FRS01352
Publication Date March 2009
Publisher Frost & Sullivan
Product Type Report
Pages 37
ISBN Number not applicable

Opportunities Assessment for Hepatitis B Therapeutics in Thailand

This research service aims to provide an update on the epidemiology of hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Thailand.

Contents

  • 1. Executive Summary
    • Market Overview
    • Hepatitis B Therapeutics Executive Summary
  • 2. Hepatitis B Therapeutics Market
    • Market Overview
    • Introduction
    • Context for the Study
    • Geographic Scope and Methodology
    • Restraints in Forecasts
  • 3. Thai Hepatitis B Therapeutics Market
    • Market Overview
    • Introduction
    • Market Engineering Measurements
    • Government Initiatives
    • Market Forecasts and Trends
    • Patient Forecasts
    • Cost of Treatment
    • Treatment and Diagnosis
    • Key Treaters and Patient Flow
    • Diagnostic Tests
    • Treatment Options
    • Duration of Treatment
    • Product Launches
    • Launched Products
    • Clinical Trials
    • Products in Clinical Trials
    • Competitive Analysis
    • Competitive Structure
    • Market Share Analysis
    • Future Trends
    • Challenges Faced by Physicians
  • 4. Appendix
  • Appendices Hepatitis B Thailand
    • Total Population and Growth Rate
    • Access Population and Percent of Total Population
    • Carriers of HBV and Percent of Access Population
    • Total CHB Patients and Percent of Carriers of HBV
    • Diagnosed Patients and Percent of CHB Patients